Open label multicenter study of once weekly Etanercept 0.8 mg/kg in active polyarticular Juvenile idiopathic arthritis (JIA)

Ítems similars

• Open label multicenter study of once weekly Etanercept 0.8 mg/kg in active polyarticular Juvenile idiopathic arthritis (JIA)
  per: Horneff G, et al.
  Publicat: (2008-09-01)
• Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab
  per: Horneff, Gerd, et al.
  Publicat: (2016)
• The German etanercept registry for treatment of juvenile idiopathic arthritis
  per: Horneff, G, et al.
  Publicat: (2004)
• Phase III, multi-centre, randomised, double blind, Placebo-controlled study for treatment of juvenile ankylosing spondylitis (AS) with Adalimumab
  per: Horneff, G, et al.
  Publicat: (2011)
• Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry
  per: Armaroli, Giulia, et al.
  Publicat: (2020)